|
1
|
Landis SH, Murray T, Bolden S and Wingo
PA: Cancer statistics, 1999. CA Cancer J Clin. 49:8–31. 1999.
View Article : Google Scholar
|
|
2
|
Bubendorf L, Schopfer A, Wagner U, et al:
Metastatic patterns of prostate cancer: an autopsy study of 1,589
patients. Hum Pathol. 31:578–583. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shah RB, Mehra R, Chinnaiyan AM, et al:
Androgen-independent prostate cancer is a heterogeneous group of
diseases: lessons from a rapid autopsy program. Cancer Res.
64:9209–9216. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rana A, Chisholm GD, Khan M, Sekharjit SS,
Merrick MV and Elton RA: Patterns of bone metastasis and their
prognostic significance in patients with carcinoma of the prostate.
Br J Urol. 72:933–936. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Inui M, Martello G and Piccolo S: MicroRNA
control of signal transduction. Nat Rev Mol Cell Biol. 11:252–263.
2010. View
Article : Google Scholar
|
|
6
|
Schickel R, Boyerinas B, Park SM and Peter
ME: MicroRNAs: key players in the immune system, differentiation,
tumorigenesis and cell death. Oncogene. 27:5959–5974. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Baranwal S and Alahari SK: miRNA control
of tumor cell invasion and metastasis. Int J Cancer. 126:1283–1290.
2010.PubMed/NCBI
|
|
8
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar
|
|
9
|
Khew-Goodall Y and Goodall GJ:
Myc-modulated miR-9 makes more metastases. Nat Cell Biol.
12:209–211. 2010.PubMed/NCBI
|
|
10
|
Nicoloso MS, Spizzo R, Shimizu M, Rossi S
and Calin GA: MicroRNAs - the micro steering wheel of tumour
metastases. Nat Rev Cancer. 9:293–302. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li T, Li D, Sha J, Sun P and Huang Y:
MicroRNA-21 directly targets MARCKS and promotes apoptosis
resistance and invasion in prostate cancer cells. Biochem Biophys
Res Commun. 383:280–285. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Spahn M, Kneitz S, Scholz CJ, et al:
Expression of microRNA-221 is progressively reduced in aggressive
prostate cancer and metastasis and predicts clinical recurrence.
Int J Cancer. 127:394–403. 2010.PubMed/NCBI
|
|
13
|
Kong D, Banerjee S, Ahmad A, et al:
Epithelial to mesenchymal transition is mechanistically linked with
stem cell signatures in prostate cancer cells. PLoS One.
5:e124452010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu C, Kelnar K, Liu B, et al: The
microRNA miR-34a inhibits prostate cancer stem cells and metastasis
by directly repressing CD44. Nat Med. 17:211–215. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kong D, Heath E, Chen W, et al: Loss of
let-7 up-regulates EZH2 in prostate cancer consistent with the
acquisition of cancer stem cell signatures that are attenuated by
BR-DIM. PLoS One. 7:e337292012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Peng X, Guo W, Liu T, et al:
Identification of miRs-143 and -145 that is associated with bone
metastasis of prostate cancer and involved in the regulation of
EMT. PLoS One. 6:e203412011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Su YJ, Lai HM, Chang YW, Chen GY and Lee
JL: Direct reprogramming of stem cell properties in colon cancer
cells by CD44. EMBO J. 30:3186–3199. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Clarke MF, Dick JE, Dirks PB, et al:
Cancer stem cells - perspectives on current status and future
directions: AACR Workshop on cancer stem cells. Cancer Res.
66:9339–9344. 2006. View Article : Google Scholar
|
|
19
|
Sun S and Wang Z: ALDH high adenoid cystic
carcinoma cells display cancer stem cell properties and are
responsible for mediating metastasis. Biochem Biophys Res Commun.
396:843–848. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Monteiro J and Fodde R: Cancer stemness
and metastasis: therapeutic consequences and perspectives. Eur J
Cancer. 46:1198–1203. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hatfield S and Ruohola-Baker H: microRNA
and stem cell function. Cell Tissue Res. 331:57–66. 2008.
View Article : Google Scholar
|
|
24
|
Xu N, Papagiannakopoulos T, Pan G, Thomson
JA and Kosik KS: MicroRNA-145 regulates OCT-4, SOX2, and KLF4 and
represses pluripotency in human embryonic stem cells. Cell.
137:647–658. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wong DJ, Segal E and Chang HY: Stemness,
cancer and cancer stem cells. Cell Cycle. 7:3622–3624. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang S, Balch C, Chan MW, et al:
Identification and characterization of ovarian cancer-initiating
cells from primary human tumors. Cancer Res. 68:4311–4320. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pfeiffer MJ and Schalken JA: Stem cell
characteristics in prostate cancer cell lines. Eur Urol.
57:246–254. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang M, Burton DW, Geller J, et al: The
bisphosphonate olpadronate inhibits skeletal prostate cancer
progression in a green fluorescent protein nude mouse model. Clin
Cancer Res. 12:2602–2606. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bisson I and Prowse DM: WNT signaling
regulates self-renewal and differentiation of prostate cancer cells
with stem cell characteristics. Cell Res. 19:683–697. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Patrawala L, Calhoun T,
Schneider-Broussard R, et al: Highly purified CD44+
prostate cancer cells from xenograft human tumors are enriched in
tumorigenic and metastatic progenitor cells. Oncogene.
25:1696–1708. 2006.PubMed/NCBI
|
|
31
|
Trerotola M, Rathore S, Goel HL, et al:
CD133, Trop-2 and alpha2beta1 integrin surface receptors as markers
of putative human prostate cancer stem cells. Am J Transl Res.
2:135–144. 2010.PubMed/NCBI
|
|
32
|
Zöller M: CD44: can a cancer-initiating
cell profit from an abundantly expressed molecule? Nat Rev Cancer.
11:254–267. 2011.PubMed/NCBI
|
|
33
|
Schoenhals M, Kassambara A, De Vos J, Hose
D, Moreaux J and Klein B: Embryonic stem cell markers expression in
cancers. Biochem Biophys Res Commun. 383:157–162. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu C and Tang DG: MicroRNA regulation of
cancer stem cells. Cancer Res. 71:5950–5954. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sachdeva M, Zhu S, Wu F, et al: p53
represses c-Myc through induction of the tumor suppressor miR-145.
Proc Natl Aca Sci USA. 106:3207–3212. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang YP, Chien Y, Chiou GY, Cherng JY,
Wang ML, Lo WL, et al: Inhibition of cancer stem cell-like
properties and reduced chemoradioresistance of glioblastoma using
microRNA145 with cationic polyurethane-short branch PEI.
Biomaterials. 33:1462–1476. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chiou GY, Cherng JY, Hsu HS, et al:
Cationic polyurethanes-short branch PEI-mediated delivery of Mir145
inhibited epithelial-mesenchymal transdifferentiation and cancer
stem-like properties and in lung adenocarcinoma. J Control Release.
159:240–250. 2012. View Article : Google Scholar
|
|
38
|
Lee MY, Lu A and Gudas LJ: Transcriptional
regulation of Rex1 (zfp42) in normal prostate epithelial cells and
prostate cancer cells. J Cell Physiol. 224:17–27. 2010.PubMed/NCBI
|
|
39
|
Hayashida T, Jinno H, Kitagawa Y and
Kitajima M: Cooperation of cancer stem cell properties and
epithelial-mesenchymal transition in the establishment of breast
cancer metastasis. J Oncol. 2011:5914272011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mani SA, Guo W, Liao MJ, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Morel AP, Lièvre M, Thomas C, Hinkal G,
Ansieau S and Puisieux A: Generation of breast cancer stem cells
through epithelial-mesenchymal transition. PLoS One. 3:e28882008.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Pirozzi G, Tirino V, Camerlingo R, et al:
Epithelial to mesenchymal transition by TGFβ-1 induction increases
stemness characteristics in primary non small cell lung cancer cell
line. PLoS One. 6:e215482011.
|
|
43
|
Li H, Chen X, Calhoun-Davis T, Claypool K
and Tang DG: PC3 human prostate carcinoma cell holoclones contain
self-renewing tumor-initiating cells. Cancer Res. 68:1820–1825.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang K and Waxman DJ: PC3 prostate
tumor-initiating cells with molecular profile
FAM65Bhigh/MFI2low/LEF1low
increase tumor angiogenesis. Mol Cancer. 9:3192010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Morton RA, Ewing CM, Nagafuchi A, Tsukita
S and Isaacs WB: Reduction of E-cadherin levels and deletion of the
alpha-catenin gene in human prostate cancer cells. Cancer Res.
53:3585–3590. 1993.PubMed/NCBI
|
